AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Psyfax 37.5 ER Capsule

Prescription Icon
Prescription Required

Marketer

Psychocare Health Pvt Ltd

Salt Composition

Venlafaxine (37.5mg)

Overview Psyfax 37.5 ER Capsule

NeuroBalance 37.5 mg extended-release capsules treat depressive and anxiety disorders. This medication modifies brain chemistry, alleviating anxiety symptoms like agitation, unease, poor focus, tiredness, perspiration, rapid heartbeat, and intrusive thoughts. Take NeuroBalance 37.5 mg with food, at the same time daily for consistent blood levels. If a dose is missed, take it promptly; don't skip doses, and complete the prescribed course even with symptom improvement. Abrupt cessation may worsen symptoms. Common side effects include queasiness, vomiting, sleeplessness, reduced appetite, heightened anxiety, constipation, increased sweating, and sexual difficulties. Dizziness and drowsiness are possible; avoid driving or tasks demanding concentration until the medication's effects are known. These effects are usually temporary and self-limiting. Consult your physician if they persist or are bothersome. Before starting NeuroBalance 37.5 mg, disclose kidney, heart, or liver problems, and any seizure history. Report unusual mood or behavioral shifts, new or worsening depression, or suicidal thoughts to your doctor immediately.

Uses of Psyfax 37.5 ER Capsule

Mood disorders encompassing depressive and anxious symptoms

Major Benefits of Psyfax 37.5 ER Capsule:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the entire capsule; do not crush, chew, or fracture it. Psyfax 37.5 ER Capsules should be administered with a meal.

Common Side effects of Psyfax 37.5 ER Capsule:

  • Nausea
  • Vomiting
  • Dizziness
  • Insomnia (difficulty in sleeping)
  • Decreased appetite
  • Anxiety
  • Constipation
  • Increased sweating
  • Sexual dysfunction

How to use Psyfax 37.5 ER Capsule:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Psyfax 37.5 ER Capsule whole; avoid crushing, chewing, or breaking it. Administer this capsule with a meal.

How Psyfax 37.5 ER Capsule works:

Psyfax 37.5 ER Capsules elevate brain levels of serotonin and noradrenaline, neurotransmitters crucial for preserving cognitive equilibrium.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Psyfax 37.5 ER Capsules with alcohol is dangerous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Psyfax 37.5 ER Capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Psyfax 37.5mg capsule is likely unsuitable for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant. Close observation of infants for drowsiness and appropriate weight increase is recommended.

DrivingDrivingUNSAFE

Driving ability may be impaired by Psyfax 37.5 ER Capsule, due to potential side effects including dizziness, confusion, and visual disturbances like blurred vision.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Psyfax 37.5 ER Capsules. Dosage modification may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Psyfax 37.5 ER Capsules cautiously; dosage modification may be necessary. Physician consultation is recommended.

What if you forget to take Psyfax 37.5 ER Capsule :

Should you forget a Psyfax 37.5 ER Capsule dose, administer it promptly. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed amount.

Facts to Know About Psyfax 37.5 ER Capsule

LabelValue
Chemical Type Anisole-based compound
Developing Habits No.
Treatment Category Neuroscience of the Central Nervous System
Action Category SNRIs (serotonin-norepinephrine reuptake inhibitors)

FAQs on Psyfax 37.5 ER Capsule

Sedation is a possible side effect of Psyfax 37.5 ER Capsules. Inform your doctor about any other sleep aids you're using before taking this medication.
Yes. Psyfax 37.5 ER capsules are psychotropic medications; these drugs alter mental function, mood, and behavior.
Psyfax 37.5 ER Capsules are not narcotics. Narcotics are opioid-derived drugs, such as heroin and morphine, that cause drowsiness.
Psyfax 37.5 ER and XR capsules are identical extended-release formulations. This slow release maintains consistent drug levels, reducing the frequency of dosing.
Mirtazapine and Psyfax 37.5 ER Capsules together pose a serious risk of serotonin syndrome, a potentially life-threatening condition. Symptoms may include agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, fluctuating blood pressure, high fever, and coma.
Combining citalopram and Psyfax 37.5 ER capsules, which both raise serotonin levels, risks causing serotonin syndrome. This potentially life-threatening condition may manifest as agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, fluctuating blood pressure, high fever, and coma. An alternative medication should be considered.
P-glycoprotein pumps Psyfax 37.5 ER Capsule out of the brain. However, some research indicates that Psyfax 37.5 ER Capsule and its metabolite can inhibit p-glycoprotein activity.
The liver metabolizes Psyfax 37.5 ER Capsules before intestinal absorption.
Psyfax 37.5 ER Capsules treat generalized depressive disorder. Physician consultation is required before use.
Treatment with Psyfax 37.5 ER Capsules may cause a sustained rise in blood pressure in some individuals. Regular blood pressure monitoring is advised for patients taking this medication; dose reduction or treatment discontinuation may be necessary.
Constipation is a known side effect of Psyfax 37.5 ER Capsules in some users. Increase fiber and water intake; laxatives may also help. Your doctor can advise on prevention and management. Contact your doctor if constipation persists or worsens.
Yes, Psyfax 37.5 ER Capsules have been associated with weight loss in some patients. Studies show this weight loss increases with higher doses and longer treatment durations. Consult your physician if concerned.
Psyfax 37.5 ER Capsules are not considered habit-forming.
While a tablet may be substituted for a capsule, this should only occur with a doctor's guidance and prescription. Altering your medication independently is risky, as differing formulations affect drug release and may result in inadequate treatment, side effects, or treatment failure.
Gabapentin may be used with Psyfax 37.5 ER Capsules, but only under a doctor's supervision. Concurrent use can increase drowsiness, sleepiness, and impair concentration. Caution is advised.
Desvenlafaxine is the active ingredient in Psyfax 37.5 ER Capsule.
While some studies suggest Psyfax 37.5 ER Capsules may be effective for fibromyalgia, it's not currently approved for this use. Always consult your doctor before taking this medication.
While not FDA-approved for nerve pain, Psyfax 37.5 ER Capsules have shown efficacy in some research studies, leading to their off-label use for this condition.
Psyfax 37.5 ER Capsules reduce appetite by altering brain neurotransmitter levels; this effect increases with higher doses.
Experience decreased sex drive or impotence? Consult your doctor; alternative medications may be available. Do not discontinue Psyfax 37.5 ER Capsule without medical supervision; doing so may worsen side effects.
Psyfax 37.5 ER Capsule
33
MRP 40
17% off